Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp268 | Genetics | ECTS2013

No mutations in the serotonin related TPH1 and HTR1B genes in patients with monogenic sclerosing bone disorders

Boudin Eveline , Jennes Karen , de Freitas Fenna , Tegay David , Mortier Geert , Van Hul Wim

Since the identification of LRP5 as the causative gene for the osteoporosis pseudoglioma syndrome (OPPG) as well as the high bone mass (HBM) phenotype, LRP5 and the Wnt/β-catenin signalling have been extensively studied for their role in the differentiation and proliferation of osteoblasts, in the apoptosis of osteoblasts and osteocytes and in the response of bone to mechanical loading. However, more recently the direct effect of LRP5 on osteoblasts and bone formation has...

ba0001pp290 | Muscle, physical activity and bone | ECTS2013

Response of mechanically strained tenocytes to different cell culture substrates

Musson David , JungJoo Kim , Callon Karen , Naot Dorit , Shim Vickie , Anderson Iain , Cornish Jillian , Chhana Ashika

The musculoskeletal system experiences severe mechanical strain, with repetitive or extreme strains causing significant trauma; the result being an increase in mechanobiological studies evaluating mechanical strain on musculoskeletal cells. Currently, most stretching studies utilise fibronectin-coated cultures, as these enhance cell attachment. However, recent studies suggest that fibronectin increases cell turnover and DNA damage and affects cell differentiation. Furthermore,...

ba0001pp497 | Other diseases of bone and mineral metabolism | ECTS2013

A frameshift mutation in receptor activator of NF-κB reveals a potential ligand-independent mechanism for NF-κB activation

Dignan Cahal , Mellis David , Duthie Angela , Pangrazio Alessandra , Sobacchi Cristina , Schulz Ansgar , Helfrich Miep , Crockett Julie

Osteoclast-poor autosomal recessive osteopetrosis is characterised by susceptibility to fracture despite high bone mineral density as a consequence of an absence of osteoclasts. One of the 12 receptor activator of NF-κB (RANK) mutations associated with this condition is a frameshift mutation encoding a protein that is truncated within the extracellular, N-terminal domain (R110Pfs). We investigated the effect of this mutation on osteoclast formation, receptor localisation ...

ba0002p132 | (1) | ICCBH2013

Studies on bone and osteoclasts in patients with Shwachman Diamond syndrome

Helfrich Miep , Mellis David , Coxon Fraser , Greenhorn John , Kuijpers Taco , Crockett Julie

Shwachman Diamond syndrome (SDS; MIM 260400) is a monogenic, autosomal recessive, pancreatic condition often accompanied by low bone mass and fracture. In SDS, as in cystic fibrosis, a low bone mass may be secondary to poor nutrition or chronic low-grade infection, but it has also been suggested there may be a primary bone phenotype. Paradoxically, recent studies in cell lines and in a mouse knockout for the SBDS gene, have suggested changes in important osteoclast gr...

ba0002p138 | (1) | ICCBH2013

Rare mutations associated with osteoclast-poor osteopetrosis provide molecular insights into receptor activator of NFκβ signalling

Crockett Julie , Das Subhajit , Dignan Cahal , Mellis David , Duthie Angela , Sobacchi Cristina , Schulz Ansgar , Helfrich Miep

Twelve different mutations in TNFRSF11A (encoding the RANK receptor) have been associated with osteoclast-poor autosomal recessive osteopetrosis in patients. Two truncated RANK proteins resulting from substitution mutations (W434X and G280X), identified in two infants, cause loss of the intracellular oligomerisation motif and in the case of the G280X mutation the TRAF6 binding domain. A third mutation was identified in a 10-year-old patient and is a frameshift mutatio...

ba0003pp11 | Arthritis and other joint diseases: translational and clinical | ECTS2014

Multinucleated giant cells in synovia from people with rheumatoid arthritis or osteoarthritis

Prieto-Potin Ivan , Largo Raquel , Roman-Blas Jorge A , Herrero-Beaumont Gabriel , Walsh David A

Aims: To describe different multinucleated giant cell phenotypes and their associations with synovitis in people with rheumatoid arthritis (RA) or osteoarthritis (OA), and in an experimental model of chronic arthritis.Material and methods: A cross-sectional comparative study was performed on samples of knee synovia from age-matched patients with RA, OA, or non-arthritic post mortem (PM) controls. OA synovia were stratified by histological inflammation gr...

ba0003pp25 | Bone biomechanics and quality | ECTS2014

Normal bone matrix mineralization in patients with chronic obstructive pulmonary disease

Misof Barbara , Roschger Paul , Jorgetti Vanda , Klaushofer Klaus , Dempster David , Kulak Carolina

Chronic obstructive pulmonary disease (COPD) has been found associated with low areal bone mineral density and an increase in fracture rate. Previous histomorphometric findings revealed abnormally low cancellous bone volume and thin cortices. In the present work, we studied the same transiliac bone biopsy samples from n=19 COPD patients for cancellous (Cn.) and cortical (Ct.) bone mineralization density distribution (BMDD) based on quantitative backscatter electron im...

ba0004oc2 | (1) | ICCBH2015

Feature-based recognition of trabecular microstructure using 1.5T magnetic resonance imaging: a new methodology

Dimitri Paul , Lekadir Karim , Hoogendoorn Corne , Armitage Paul , Whitby Elspeth , King David , Frangi Alejandro

Background: Magnetic resonance imaging (MRI) is used clinically to assess bone marrow, muscle and joints. The assessment of cortical and trabecular structure using MRI may provide further insight into the muscle–bone–bone marrow unit. Previous studies using MRI to evaluate microarchitecture are confined to research due to the need for specially adapted coils and navigator software to limit motion artifact. We present a novel statistical method using HRpQCT to determi...

ba0004oc8 | (1) | ICCBH2015

Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta

Munns Craig , Peacock Lauren , Mikulec Kathy , Kneissel Michaela , Kramer Ina , Cheng Tegan , Schindeler Aaron , Little David

Introduction: Bisphosphonate treatment in children with osteogenesis imperfecta reduces bone catabolism and relies on modelling to form new bone. An anabolic treatment, anti-sclerostin antibody (Anti-SOST Ab), is being investigated in clinical trials. We hypothesized that combined treatment may produce superior outcomes in OI.Methods: Female Col1a2 G610C mice and their wild type littermates (WT) were treated from week 5 to week 9 of life with either sali...

ba0004lb1 | (1) | ICCBH2015

Maternal vitamin D depletion disrupts neonatal skeletal development in mice

Buckley Harriet , Borg Stephanie , Nicholson Kirsty , Kinch Mark , Hughes David , Skerry Tim , Bishop Nick

Fractures in infancy raise the spectre of child abuse; it has been suggested that lack of vitamin D could result in bone abnormalities that could predispose to fractures. We utilised a mouse model system to investigate whether vitamin D deficiency in utero alters early bone growth and development.C57BL/6 female mice received vitamin D deficient or replete diet for 6 weeks, then mated and continued on their respective diets until weaning. Pups were culled...